Bicycle Therapeutics (BCYC) Current Assets (2018 - 2026)

Bicycle Therapeutics has reported Current Assets for 9 years, with the latest figure at $619.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 27.68% year-over-year to $619.1 million; the trailing twelve-month figure through Mar 2026 stood at $619.1 million (down 27.68% YoY), and the FY2025 full-year result was $682.9 million, down 26.46% from the prior year.
• Current Assets for Q1 2026 stood at $619.1 million, down from $682.9 million in the prior quarter.
• The five-year high for Current Assets was $1.0 billion in Q2 2024, with the low at $369.4 million in Q4 2022.
• Historically, Current Assets has averaged $628.5 million across 5 years, with a median of $603.0 million in 2023.
• Annual changes were most pronounced in 2024 — Current Assets jumped 151.76% — and 2026, when it fell 27.68%.
• Bicycle Therapeutics' Current Assets stood at $369.4 million in 2022, then surged by 52.11% to $561.9 million in 2023, then jumped by 65.27% to $928.6 million in 2024, then retreated by 26.46% to $682.9 million in 2025, then slipped by 9.34% to $619.1 million in 2026.
• The last three Current Assets figures came in at $619.1 million (Q1 2026), $682.9 million (Q4 2025), and $738.8 million (Q3 2025), per Business Quant data.